Background: Mangifera mekongensis (Anacardiaceae) is cultivated for its edible fruit and has been used in traditional Vietnamese medicine for its anti-aging properties and for treating diabetes, vermifuge, and dysentery. As part of a search for biologically active compounds with reduction of the rate of glucose absorption, a screening has been initiated to evaluate natural product extracts for the inhibition of enzyme α-glucosidase. A n-hexane extract of the bark of M. mekongensis showed strong α-glucosidase inhibitory activity with IC 50 value of 1.71 µg/mL. Thus, the constituents of this plant were examined.
Background
Mangifera mekongensis (Anacardiaceae), commonly known as mango, is widely distributed in tropical and subtropical regions of Asia. In Vietnam, M. mekongensis is called as "Xoai Thanh Ca", and this plant is cultivated for its edible fruit and has been used in traditional Vietnamese medicine for treating anti-aging, diabetes, vermifuge, dysentery [1, 2] . A research for biologically active compounds with reduction of the rate of glucose absorption, a screening has been initiated to evaluate natural product extracts for the inhibition of enzyme α-glucosidase. It is effective in controlling postprandial hyperglycaemia and prevents complications associated with type-II diabetes, such as microvascular (i.e., retinal, renal, and possibly neuropathic), macrovascular (i.e., coronary and peripheral vascular), and neuropathic (i.e., autonomic and peripheral) complications [3, 4] . Previously, we reported that the methanolic extracts of Embelia ribes, Oroxylum indicum, and Artocarpus altilis exhibited significant inhibitory activity on α-glucosidase [5] [6] [7] [8] . In a part of our continued research on the screening of medicinal plants of different origins, we also found that the n-hexane extract of the bark of M. mekongensis showed strong α-glucosidase inhibitory activity with IC 50 value of 1.71 µg/mL. Thus, we carried out the bioactivity-guided fractionation of n-hexane extract of this plant and isolated two new steroids, mekongsterols A (1) and B (2), together with seven known compounds (3-9) (Fig. 1) . In this paper, we describe the isolation and structural elucidation of these compounds by spectroscopic methods as well as their α-glucosidase inhibitory activity. 
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Result and discussion
Chemistry
The dried powdered bark of M. mekongensis was extracted with n-hexane in Soxhlet extractor to yield n-hexane fraction. Further separation and purification of this fraction led to the isolation of two new steroids, mekongsterols A (1) and B (2), together with seven known compounds (3) (4) (5) (6) (7) (8) (9) . The known compounds were identified by the analysis of their spectroscopy data and comparing with the literature data to be as β-sitosterol (3) [9] , stigmastane-3,6-dione (4) [10] , β-sitosteryl-3-O-β-D-glucopyranosyl-6′-O-palmitate (5) [11] , mangiferonic acid (6) [12] , mangiferolic acid (7) [12] , ambonic acid (8) [13] , and ambolic acid (9) [12] (Fig. 1 7 and 139.9) . These data closely resembled those of β-sitosterol (3) [9] , a common steroid found in plants, but they were characterized by the presence of additional signals due to a saturated fatty ester chain having 19C, which showed ester carbonyl (δ C 173.5), many methylenes (δ H 1.20-2.27; δ C 22.8-34.9), and one methyl triplet (δ H 0.88, t, J = 6.9 Hz). The location of saturated fatty ester chain was determined to be at C-3 on the basis of the low-field shift of H-3 (δ H 4.62) compared to that of 3 (δ H 3.51), which was confirmed by the HMBC correlation from H-3 to C-1′ (Fig. 2) . The orientation of saturated fatty ester group at C-3 was determined β-equatorial from the NOESY correlations H-3/H-2α and H-3/H-4α, and large J value (7.7 Hz) between H-3 and H-4β ( C data were similar to those of β-sitosterol (3) [9] , the steroid isolated from the same extract, except for the presence of additional signals due to monoester derivative of nonadioic acid. This was confirmed by the COSY and HSQC spectra, and from them, the partial structure C(2′)H 2 -C(3′)H 2 -C(4′)H 2 -C(5′)H 2 -C(6′)H 2 -C(7′) H 2 -C(8′)H 2 were deduced. Furthermore, the HMBC correlations from two methylene groups H 2 -2′ and H 2 -3′ to the ester carbonyl carbon C-1′, while two methylene groups H 2 -7′ and H 2 -8′ gave significant correlations to the acid carbonyl carbon C-9′ suggesting the monoester azelaic acid. The location of this moiety was determined to be at C-3 based on HMBC correlations from H-3 to C-1′ (Fig. 2) . The configuration of monoester nonadioic acid moiety at C-3 to be β-equatorial orientation from the NOESY correlations H-3/H-2α and H-3/H-4α, and large J value (7.6 Hz) between H-3 and H-4β (Fig. 3) . The relative stereochemistry of 2 was confirmed to be the same as 1 based on the results of difference NOE experiments. Thus, the structure of 2 was concluded as 3β-(8-carboxyoctanoyl)sitosterol (mekongsterol B).
Biological assay
Among three fractions extracted from the bark of M. Mekongensis, n-hexane fraction showed α-glucosidase inhibitory activity with IC 50 value of 17.1 µg/mL. This fraction was subjected to silica gel column chromatography to yield twelve fractions. All these fractions possessed inhibitory activity, with IC 50 values ranging from 1.9 to 69.3 μg/mL ( Table 2) .
The isolated compounds were tested for their α-glucosidase inhibitory activity (Table 3 ). The assay was carried out at various concentrations ranging from 1 to 250 µM. Compounds 1, 2, 5-9 possessed significant α-glucosidase inhibitory activity in a concentrationdependent manner, and showed more potent inhibitory activity, with IC 50 values ranging from 1.2 to 112.0 μM, than that of a positive control acarbose (IC 50 , 214.5 μM), which is currently used clinically in combination with either diet or anti-diabetic agents to control blood glucose level of patients [14] . Among isolated compounds, the sterol compounds (1-5) with saturated fatty ester chain or sugar group at C-3 (1, 2, and 5) showed potent α-glucosidase inhibitory activity, while the compounds with hydroxyl or ketone grop at C-3 (3 and 4) were inactive. On the other hand, all isolated cycloartane triterpenes (6-9) showed strong α-glucosidase inhibitory activity, however, their structure-activity relationships 
Methods
General experimental procedures
The IR spectra were measured with a Shimadzu IR-408 spectrophotometer in CHCl 3 solution. The NMR spectra were taken on a Bruker Advance III 500 spectrometer with tetramethylsilane (TMS) as an internal standard, and chemical shifts are expressed in δ values. The HR-ESI-MS was performed on a Bruker MicroTOF-QII spectrometer. The absorbance (OD) was measured with a Shimadzu UV-1800 UV-Vis spectrophotometer. 
Plant material
The bark of M. mekongensis was collected at Ben Tre province, Vietnam, in March 2013, and was identified by Ms. Hoang Viet, Faculty of Biology, University of Science, Vietnam National University-Hochiminh City (VNU-HCMC). A voucher specimen (MDE0047) was deposited at the Division of Medicinal Chemistry, Faculty of Chemistry, University of Science, VNU-HCMC.
Extraction and isolation
The dried powdered bark of M. mekongensis (6.0 kg) was refluxed with n-hexane (5.0 L) in Sohxlet extractor to yield a n-hexane fraction (14. then extracted with MeOH (5.0 L) to give MeOH fraction (108.0 g). The n-hexane fraction (12.5 g) was subjected to silica gel column (6.5 × 120 cm) chromatography, eluted with acetone-n-hexane (0-80 %) to yield 12 fractions: fr. 1 (0.1 g), fr. 2 (1.8 g), fr. 3 (1.1 g), fr. 4 (2.6 g), fr. 5 (1.4 g), fr. 6 (0.8 g), fr. 7 (0.3 g), fr. 8 (0.8 g), fr. 9 (0.7 g), fr. 10 (0.6 g), fr. 11 (0.9 g), fr. 12 (1.4 g). All extractions and fractions were tested for their α-glucosidase inhibitory activity (Table 2) . Fraction 2 (1.8 g) was applied to silica gel column chromatography with acetone-n-hexane gradient system to give six subfractions (fr. 2.1, 1.2 g; fr. 2.2, 134 mg; fr. 2.3, 75 mg; fr. 2.4, 47 mg; fr. 2.5, 89 mg; fr. 2.6, 270 mg). Subfraction 2.1 was chromatographed further using an CHCl 3 -n-hexane (0-80 %) to yield six subfractions fr. 2.1.1-6; fr. 2.1.1 (451 mg) was separated further using an EtOAc-n-hexane (0-30 %) to afford 1 (25.0 mg).
Fraction 4 (2.6 g) was chromatographed on silica gel column chromatography, eluted with EtOAc-n-hexane gradient system to give six subfractions (fr. Fraction 5 (1.4 g) was rechromatographed to silica gel column chromatography with CHCl 3 -n-hexane gradient system to yield seven subfractions (fr. 5.1, 81 mg; fr. 5.2, 94 mg; fr. 5.3, 57 mg; fr. 5.4, 260 mg; fr. 5.5, 190 mg; fr. 5.6, 88 mg; fr. 5.7, 630 mg). Subfraction 5.3 was chromatographed with EtOAc-n-hexane (0-50 %), and then purified by normal-phase preparative TLC with CHCl 3 (100 %) to give 3 (2.5 mg).
Fraction 6 (0.8 g) was applied to silica gel column chromatography, eluted with CHCl 3 -n-hexane gradient system to yield five subfractions (fr. 6.1, 124 mg; fr. 6.2, 192 mg; fr. 6.3, 272 mg; fr. 6.4, 42 mg g; fr. 6.5, 130 mg). Subfraction 6.1 was also chromatographed on silica gel with EtOAc-n-hexane (0-80 %), and then followed by normal-phase preparative TLC with ethyl acetaten-hexane (25:75) to give 2 (8.0 mg). Subfraction 6.2 was rechromatographed further using EtOAc-n-hexane (0-80 %) and then purified by normal-phase preparative TLC with CHCl 3 -n-hexane (10:90) to give 6 (6.0 mg) and 8 (10.0 mg).
Fraction 9 (0.7 g) was chromatographed on silica gel column chromatography, eluted with CHCl 3 -n-hexane gradient system to give four subfractions (fr. 9.1, 150 mg; fr. 9.2, 125 mg; fr. 9.3, 360 mg; fr. 9.4, 47 mg). Subfraction 9.3 was subjected to silica gel with EtOAc-n-hexane (0-80 %) to yield two subfractions fr. 9.3.1-2; fr. 9.3.1 (190 mg) was separated further using a CHCl 3 -n-hexane (0-80 %), and then purified by normal-phase preparative TLC with EtOAc-n-hexane (10:90) to give 7 (6.0 mg) and 9 (10.0 mg).
Fraction 11 (0.9 g) was chromatographed on silica gel column chromatography, eluted with CHCl 3 -MeOH gradient system to give five subfractions (fr. 11.1, 42 mg; fr. 11.2, 139 mg; fr. 11.3, 93 mg; fr. 11.4, 30 mg; fr. 11.5, 570 mg). Subfraction 11.2 was subjected to silica gel with EtOAc-n-hexane (0-50 %) to yield two subfractions fr. 11.1.1-2; fr. 11.2.1 (60 mg) was separated further using an CHCl 3 -MeOH (0-30 %), and then purified by normal-phase preparative TLC with CHCl 3 -MeOH (96:4) to afford 5 (8.0 mg). 
